2m 2m 2m 2m 2m 2m 2m
Celyad Onco (CLYYF)
OTC
$0.25-$0.10 (-28.57%)
Price as of Apr 23, 2026- $8.1MMarket Cap
- -61.54%1-Year Change
- BiotechnologyIndustry
Celyad Onco (CLYYF)
$0.25-$0.10 (-28.57%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.25
$0.25
$0.25
1-Year Range
$0.15
$0.53
$0.25
Latest Close$0.25
Change
-$0.10 (-40.00%)
Volume8,063
Market Cap$8.1M
Shares Outstanding44.8M
P/E (TTM)-0.10
Diluted EPS (TTM)-$1.81
Enterprise Value-$4.4M
Information as of 04/23/2026
Company Profile
CELYAD SA
$8.1M
Market Cap
-$40.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
CELYAD SA
Key Executives
- Matthew R. Kane
- Michel E. J. Lussier
- Sara Zelkovic
- Philippe Dechamps
- Hannes Iserentant
Current Ownership Distribution
- Other44.8M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)